Purpose
to determine if pyronaridine/artesunate (Pyramax) plus single low dose (SLD) primaquine (PQ) will be effective in reducing gametocyte density and onward parasite transmission as part of case management
Grantee
Division
Global Health
Date
JULY 2019
Region served
AFRICA
Committed amount
$1,269,568
Grant topic
Malaria
Duration (months)
54
Grantee location
London, United Kingdom
Related work
More about our financials
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.